Ignite Creation Date:
2024-05-05 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00768196
Status:
COMPLETED
Last Update Posted:
2010-12-07
First Post:
2008-10-01
Brief Title:
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease GERD-Q in Korean GERD Patients
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease GERD-Q in Korean GERD Patients
Status:
COMPLETED
Status Verified Date:
2010-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Preedom
Brief Summary:
The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None